Institution

Rheumazentrum Ruhrgebiet

Herne, GermanyWebsite

10running trials
3closed trials
2,129publications (OpenAlex)

Running trials

Not yet recruiting
Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis
NCT07018206· Phase 4· CARE ARTHRITIS LTD.· Source
Recruiting
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
NCT07137598· Phase 2· Hoffmann-La Roche· Source
Recruiting
EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)
NCT07047703· Phase 1/2· Grey Wolf Therapeutics· Source
Active, not recruiting
A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)
NCT07015983· Phase 2· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Source
Recruiting
A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING
NCT06712628· AbbVie· Source
Active, not recruiting
Avacostar - (PASS)
NCT05897684· Vifor Fresenius Medical Care Renal Pharma· Source
Active, not recruiting
A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis
NCT05785611· Phase 3· Alfasigma S.p.A.· Source
Active, not recruiting
A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who Receive Upadacitinib in a Real-world Setting
NCT05094128· AbbVie· Source
Active, not recruiting
A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice
NCT05049798· Janssen Pharmaceutica N.V., Belgium· Source
Active, not recruiting
Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis
NCT04871919· Alfasigma S.p.A.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Ankylosing spondylitis2 recruiting
Rheumatoid arthritis2 recruiting

Closed trials

Completed
An Observational Study to Assess Change in Disease Activity and Treatment Patterns of Upadacitinib When Given Alone or Co-Administered With Methotrexate in Adult Participants With Active Psoriatic Arthritis
NCT05616871· AbbVie· Source
Completed
Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA Patients
NCT04485325· Phase 4· Dr. Frank Behrens· Source
Completed
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)
NCT03104400· Phase 3· AbbVie· Source

Registry name variants (13)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

Rheumazentrum Ruhrgebiet
Herne, 44649
7 trials
Katholische Kliniken Rhein-Ruhr, St. Elisabeth Gruppe GmbH, Rheumazentrum Ruhrgebiet
Herne
1 trial
- NCT04485325Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA Patients
Rheumazentrum Ruhrgebiet /ID# 163930
Herne, North Rhine-Westphalia 44649
1 trial
- NCT03104400A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)
Rheumazentrum Ruhrgebiet /ID# 240460
Herne, North Rhine-Westphalia 44649
1 trial
- NCT05094128A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who Receive Upadacitinib in a Real-world Setting
Rheumazentrum Ruhrgebiet /ID# 252939
Herne, North Rhine-Westphalia 44649
1 trial
- NCT05616871An Observational Study to Assess Change in Disease Activity and Treatment Patterns of Upadacitinib When Given Alone or Co-Administered With Methotrexate in Adult Participants With Active Psoriatic Arthritis
Rheumazentrum Ruhrgebiet /ID# 275518
Herne, North Rhine-Westphalia 44649
1 trial
- NCT06712628A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING
Rheumazentrum Ruhrgebiet, Ruhr-University Bochum
Bochum
1 trial
- NCT07047703EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)
  Contact: Grey Wolf Therapeutics Patient enquiries
Rheumazentrum Ruhrgebiet /ID# 145620
Herne, North Rhine-Westphalia 44649
Rheumazentrum Ruhrgebiet /ID# 207212
Herne, North Rhine-Westphalia 44649
Rheumazentrum Ruhrgebiet /ID# 207216
Herne, North Rhine-Westphalia 44649
Rheumazentrum Ruhrgebiet /ID# 252670
Herne, North Rhine-Westphalia 44649
Rheumazentrum Ruhrgebiet (Site 0600)
Herne, North Rhine-Westphalia 44649
Rheumazentrum Ruhrgebiet (Site 6400)
Herne, North Rhine-Westphalia 44649

Conditions

Diseases this institution publishes on or runs trials for.

Ankylosing spondylitis51 works · 4 trials
Psoriatic arthritis36 works · 3 trials
ANCA-associated vasculitis4 works · 1 trial
Polymyalgia rheumatica4 works · 0 trials

Institution data: ROR 00e03sj10 (CC0-1.0)Updated 14 Nov 2026

Report an error